Here’s a retraction from Stem Cells and Development that we’re just now getting around to covering. The paper, “Non-viral reprogramming of skeletal myoblasts with valproic acid for pluripotency,” appeared in June 2012 in a preliminary online form and was written by a group at the University of Cincinnati. As the retraction notice states:
On Wednesday, we brought you the story of a retraction by Gerold Feuer, a State University of New York (SUNY) Upstate Medical Center stem cell scientist whom the university had found to have misused grants. He was suspended, but successfully fought that action. We had asked Feuer for comment at that time, and he has … Continue reading Stem cell scientist says data in retracted paper “is not falsified or fabricated”
Stem Cells and Development has retracted a paper it published earlier this year after the leader of the study reported that the data were unreliable. The paper, “Derivation and Genetic Modification of Embryonic Stem Cells from Disease-Model Inbred Rat Strains,” came from the lab of Aron Geurts, of the Medical College of Wisconsin. According to … Continue reading Embryonic stem cell paper retracted for fabrication
A stem cell journal is retracting a paper by Gerold Feuer, a researcher at the State University of New York (SUNY) Upstate Medical Center in Syracuse who was also found to have misused grants. The Feuer story is complicated. Heralded in 2008 for landing $6.2 million in grants from the New York Stem Cell Board, … Continue reading Retraction appears for stem cell researcher found to have used funds for his company’s gain
Hisashi Moriguchi, who retracted two papers last year because he and his colleagues could not “guarantee the accuracy of the results and conclusions,” has now had another paper withdrawn — at least temporarily. A notice on the paper, “Autologous human cardiac stem cells transplantation for the treatment of ischaemic cardiomyopathy: first study of human-induced pluripotent … Continue reading Dubious stem cell researcher Moriguchi notches temporary withdrawal, notice of redundant publication
Cell is looking into whether the authors of a widely hailed study published last week claiming to have turned human skin cells into embryonic stem cells manipulated images inappropriately, Retraction Watch has learned. The potential image problems came to light on PubPeer, a site designed to allow for post-publication peer review. A commenter, identified as … Continue reading Cell reviewing allegations of image reuse in human embryonic stem cell cloning paper
A contested retraction in Stem Cells and Development has left the Queensland University of Technology (QUT) graduate student who fought for it in limbo, uncertain if he will earn his PhD. And many of those who didn’t want the paper retracted have a significant financial interest in a company whose work was promoted by the … Continue reading Stem cell retraction leaves grad student in limbo, reveals tangled web of industry-academic ties
It was, as Nature News wrote last month, a story that “seemed too good to be true:” Stem-cell transplant claims debunked Transplant of induced pluripotent stem cells to treat heart failure probably never happened Hisashi Moriguchi, a visiting researcher at the University of Tokyo, had claimed a result that would have put him years ahead … Continue reading Two Moriguchi stem cell papers being retracted
Shane Mayack, a former post-doc in Harvard lab of Amy Wagers, a rising star in the stem cell field, has been sanctioned by the Office of Research Integrity for misconduct. Mayack, who has defended her actions on this blog as honest error — albeit sloppiness — and has not admitted to wrongdoing, must undergo supervision … Continue reading ORI finds Harvard stem cell lab post-doc Mayack manipulated images
Last month, we brought you the story of Soo-Kyung Kang, a Seoul National University stem cell researcher who has now retracted four papers amidst questions about image manipulation in a total of 14 studies. That story has drawn a great deal of attention in Korea, with comparisons to the Woo-Suk Hwang scandal, and has even led to a … Continue reading Korean stem cell investigation expands to another researcher, and more papers